A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk

Breast Cancer Research and Treatment

Volumn 85, Issue 2, 2004, Pages 121-131

  Ahsan, Habibul ^a,b   Chen, Yu ^a   Whittemore, Alice S ^c   Kibriya, Muhammad G ^a   Gurvich, Irina ^a   Senie, Ruby T ^a,b   Santella, Regina M ^a,b  

^a Department of Medicine   (United States)

^b Columbia University ^*  (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Breast cancer; COMT; CYP1B1; Estrogen metabolism genes; Genetic epidemiology; Genetic polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1B1;

ALLELE; ARTICLE; BREAST CARCINOMA; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN METABOLISM; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL ANALYSIS;

ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 3342994396     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000025401.60794.68     Document Type: Article

References (40)

1. Service RF: New role for estrogen in cancer? Science 279: 1631-1633, 1998
2. Jan ST, Devanesan PD, Stack DE, Ramanathan R, Byun J, Gross ML, Rogan EG, Cavalieri EL: Metabolic activation and formation of DNA adducts of hexestrol, a synthetic nonsteroidal carcinogenic estrogen. Chem Res Toxicol 11: 412-419, 1998
3. Sutter TR, Tang YM, Hayes CL, Wo YY, Jabs EW, Li X, Yin H, Cody CW, Greenlee WF: Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269: 13092-13099, 1994
4. McKay JA, Melvin WT, Ah-See AK, Ewen SW, Greenlee WF, Marcus CB, Burke MD, Murray GI: Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett 374: 270-272, 1995
5. Taylor MC, McKay JA, Murray GI, Greenlee WF, Marcus CB, Burke MD, Melvin WT: Cytochrome P450 1B1 expression in human malignant tumours. Biochem Soc Trans 24: 328S, 1996
6. Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, Li Y, Sutler TR: Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19: 291-298, 1998
7. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD, Melvin WT: Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57: 3026-3031, 1997
8. Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, Sutter TR, Greenlee WF: Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 271: 28324-28330, 1996
9. Bailey LR, Roodi N, Dupont WD, Parl FF: Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 58: 5038-5041, 1998
10. Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, Shu XO, Gao YT: Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9: 147-150, 2000
11. Watanabe J, Shimada T, Gillam EM, Ikuta T, Suemasu K, Higashi Y, Gotoh O, Kawajiri K: Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10: 25-33, 2000
12. Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE: Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol 76: 643-649, 2002
13. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J: Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34: 4202-4210, 1995
14. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD: An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 57: 5493-5497, 1997
15. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB: Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 58: 2107-2110, 1998
16. Millikan RC, Pittman GS, Tse CK, Duell E, Newman B, Savitz D, Moorman PG, Boissy RJ, Bell DA: Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis 19: 1943-1947, 1998
17. Goodman JE. Lavigne JA, Wu K, Helzlsouer KJ, Strickland PT, Selhub J, Yager JD: COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis 22: 1661-1665, 2001
18. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY: Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59: 4870-4875, 1999
19. Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, Ahn SH, Noh DY, Choe KJ, Jang U, Shin SG, Strickland PT, Hirvonen A, Kang D: Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 11: 279-286, 2001
20. Matsui A, Ikeda T, Enomoto K, Nakashima H, Omae K, Watanabe M, Hibi T, Kitajima M: Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase. Cancer Lett 150: 23-31, 2000
21. Hamajima N, Matsuo K, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, Oya H, Obata Y: Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int J Clin Oncol 6: 13-18, 2001
22. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Kang D, Vainio H, Uusitupa M, Hirvonen A: Polymorphic catechol-O- methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 635-640, 2001
23. Bergman-Jungestrom M, Wingren S: Catechol-O-Methyl-transferase (COMT) gene polymorphism and breast cancer risk in young women. Br J Cancer 85: 859-862, 2001
24. Sanderson M, Williams MA, Daling JR, Holt VL, Malone KE, Self SG, Moore DE: Maternal factors and breast cancer risk among young women. Paediatr Perinat Epidemiol 12: 397-407, 1998
25. Weiss HA, Potischman NA, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB: Prenatal and perinatal risk factors for breast cancer in young women. Epidemiology 8: 181-187, 1997
26. Ekbom A, Hsieh CC, Lipworth L, Adami HQ, Trichopoulos D: Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst 89: 71-76, 1997
27. Potischman N, Troisi R: In-utero and early life exposures in relation to risk of breast cancer. Cancer Causes Control 10: 561-573, 1999
28. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ: Evidence of prenatal influences on breast cancer risk. Lancet 340: 1015-1018, 1992
29. Sanderson M, Williams MA, Malone KE, Stanford JL, Emanuel I, White E, Daling JR: Perinatal factors and risk of breast cancer. Epidemiology 7: 34-37, 1996
30. Ahsan H, Chen Y, Whittemore AS, Senie RT, Hamilton SP, Wang Q, Gurvich I, Santella RM: Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study (submitted for publication)
31. Hsu TM, Chen X, Duan S, Miller RD, Kwok PY: Universal SNP genotyping assay with fluorescence polarization detection. Biotechniques 31: 560, 562, 564-560,8, passim, 2001
32. Chen X, Levine L, Kwok PY: Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res 9: 492-498, 1999
33. Tu IP, Balise RR, Whittemore AS: Detection of disease genes by use of family data. II. Application to nuclear families. Am J Hum Genet 66: 1341-1350, 2000
34. Whittemore AS, Tu IP: Detection of disease genes by use of family data. I. Likelihood-based theory. Am J Hum Genet 66: 1328-1340, 2000
35. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506-516, 1993
36. Schaid DJ: General score tests for associations of genetic markers with disease using cases and their parents. Genet Epidemiol 13: 423-149, 1996
37. Spielman RS, Ewens WJ: The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 59: 983-989, 1996
38. Hosmer D, Lemeshow S: Logistic Regression for Matched Case-Control Studies. Applied Logistic Regression, John Wiley & Sons, New York, 1989, pp 187-213
39. Breslow NE, Day NE: Statistical Methods in Cancer Research. - The Analysis of Case-Control Studies. Vol. I, IARC Sci. Publ. 1980, pp. 5-338
40. De VI, Hankinson SE, Li L, Colditz GA, Hunter DJ: Association of CYP1B1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 11: 489-192, 2002